Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

4

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Table 1. Comparison between CA-CDI and HA-CDI groups

Ann Clin Microbiol 2022;25:47-52. Clinical and microbiological risk factors for community-associated Clostridioides difficile infections Download table Variables CA-CDI (n = 127) HA-CDI (n = 265) P-value Age (yr) 66.9±18.9 72.1±13.5 0.0064 Sex, male 51 (40.2) 120 (45.3) 0.3386 Charlson comorbidity index 2.4±2.1 2.7±1.9 0.1109 Associated disease Biliary tract disease 3 (2.4) 8 (3.0) 0.7133 Cancer […]

Table 2. Patient characteristics of four cases with UL54 mutations alone

Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Patient No. Sex Age (yr) Underlying disease CMV disease Outcome UL54 mutations 6 Female 15 MDS, HaploPBSCT Pneumonia Retinitis Encephalitis Expired F412L 11 Female 18 AA, HaploPBSCT Pneumonia Encephalitis Expired V715M/L501I 14 Female 18 AA, HaploPBSCT Encephalitis […]

Table 1. Human cytomegalovirus UL97/UL54 gene mutations observed in this study

Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Case No. Year UL97 mutations (specimen) UL54 mutations (specimen) Viral loads 3 2019 A594P (blood) – 4.12 log IU/mL 6 2018 – F412L (blood) 3.03 log IU/mL 7 2018 L595F (blood) N408D (blood) 4.40 log copies/mL 11 […]

Table 2. Risk factors for severe or severe complicated CDI over non-severe CDI: a multivariate analysis

Ann Clin Microbiol 2022;25:17-23. Clinical and microbiological risk factors for severe Clostridioides difficile infections Download table Risk factor OR (95% CI) P-value* Advanced age 1.017 (1.001-1.034) 0.0358 History of chemotherapy 2.695 (1.016-7.146) 0.0464 Ribotype 002 3.406 (1.183-9.803) 0.0231 *Statistical significances were maintained after the adjustment for age, associated disease (cancer, pneumonia, heart failure, nutrition deficiency), […]

Table 1. Comparison of severe (or severe complicated) CDI and non-severe CDI

Ann Clin Microbiol 2022;25:17-23. Clinical and microbiological risk factors for severe Clostridioides difficile infections Download table Variable Severe or severe complicated CDI(n = 149) Non-severe CDI(n = 155) P-value Age (yr) 74.0+15.0 65.9+18.3 < 0.0001 Sex, male 70 (47.0) 70 (45.2) 0.7505 Hospital-associated 100 (67.1) 94 (60.7) 0.2411 Charlson comorbidity index 2.4+1.7 2.5+1.8 0.6365 Associated […]

Table 2. Identified polymorphisms in pvdhfr of Plasmodium vivax

Ann Clin Microbiol 2022;25:11-16. Genetic polymorphisms in the pvdhfr, pvmdr1, and pvdhps genes of Plasmodium vivax in patients at a secondary hospital in South Korea Download table Variants No. of cases pvdhfr F57L, C.292_309del 5 pvdhfr C.292_309del 2 pvdhfr H99S 3 pvdhfr S58R, S117N 1 pvdhfr C.292_309del & pvdhps M399I 1

Table 1. CBC results of patients with confirmed Plasmodium vivax infections

Ann Clin Microbiol 2022;25:11-16. Genetic polymorphisms in the pvdhfr, pvmdr1, and pvdhps genes of Plasmodium vivax in patients at a secondary hospital in South Korea Download table Patient No. Sex Age (yr) WBC (103/μL) Hb (g/dL) PLT (103/μL) Neu (%) Lym (%) Mono (%) Eos (%) Baso (%) 1 M 22 3.55 15.1 42 81.0 […]

Table 4. Resistance profile of major gram-negative pathogens (2017-2019)

Ann Clin Microbiol 2022;25:1-10. Multidrug-resistant gram-negative bacterial infections the Tamale Teaching Hospital in Northern Ghana: a three-year retrospective analysis. Download table Antibiotics No. of isolates (resistance %) Acinetobacter baumannii Enterobacter spp. Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa AMK 7 (42.8) 198 (16.2) 383 (11.8) 425 (17.7) 242 (19.4) AMP NT 156 (98.7) 241 (97.9) 272 […]